miRNA and Non-coding RNA

Date: Thursday, 9 May 2013 - Friday, 10 May 2013
Location: Boston, MA, USA

Keynote Speakers

Hakim Djaballah
CEO, Institute Pasteur - Korea

Anthony Leung
Assistant Professor, Johns Hopkins Bloomberg School of Public Health

Overview

Welcome to the miRNA and non coding RNA track of the Genomics Research conference and exhibition.

This conference will detail the cutting edge research taking place in the two fields with a particular emphasis on the complex roles microRNA play in cancer and disease,their regulation and biogenesis. The latest developments in both therapeutics and delivery of RNAi based medicines will also be discussed to help map out the commercial trends occurring in this field.

Other conference tracks at this event include Epigenetics, Advances in qPCR and Next Generation Sequencing. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

Agenda Topics

MicroRNAs as Markers for Drug Toxicity
microRNAs in Various Cancer Classes

Companion Diagnostics
Expression Patterns in Diagnostics Development
MicroRNAs in Cancer Diagnostics and Personalized Medicine
Pathological Associations/Dysregulation

Novel Technologies and Approaches for microRNA Research
Targeting microRNAs in vivo as a Therapeutic Modality
The Emerging Field of Non-coding RNAs and Their Role in Development, Physiology, and Disease

Recently-Documented Approaches for Non-coding RNA Study
Technologies for Studying Non-coding RNAs
Unmet Needs in the Field

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Andreas Bader, Director, Mirna Therapeutics Inc
Leonidas Bleris, Professor, University of Texas at Dallas
Alex Chenchik, President/CSO, Cellecta Inc
Neil Emans, CEO & Founder, Persomics
Aurora Esquela Kerscher, Assistant Professor, Eastern Virginia Medical School
Melanie Lehman, Research Scientist, Queensland University of Technology
Pieter Mestdagh, Postdoctoral Researcher, Ghent University Hospital
Alexander Pertsemlidis, Associate Professor, The University of Texas Health Science Center at San Antonio
Marcus Peter, Professor, Northwestern University
Flavia Pichiorri, Assistant Professor, The Ohio State University
Enal Razvi, Managing Director, Select Biosciences Inc
Aldo Roccaro, Senior Scientist, Dana Farber Cancer Institute
Andrei Thomas-Tikhonenko, Professor, University of Pennsylvania
Jiri Vanicek, Assistant Professor, EFPL
Emily Wang, Assistant Professor, City of Hope Beckman Research Institute